Literature DB >> 19284991

Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.

Xiaoxiao Tian1, Hao Du, Xiangsheng Fu, Kang Li, Aimin Li, Yali Zhang.   

Abstract

Recent studies have reported that Smad4 has a TGF-beta-independent function as a tumor suppressor in cooperating with beta-catenin/Lef to regulate target gene expression. The objective of this research was to study the role of Smad4 in colon cancer migration and its potential mechanism. In our study, stable colon cancer cells that have increased Smad4 expression were created using a eukaryotic vector containing Smad4-pcDNA3.1(+). Smad4 restoration directly suppressed the Wnt/beta-catenin signal activity in SW480 cells by down-regulating beta-catenin expression and altering its localization from cytoplasm and nucleus to the plasma membrane. Up-regulation of Smad4 also increased the expression of E-cadherin and decreased the transcriptional activity of beta-catenin/Tcf target genes, such as claudin-1 and MMP-7. SW480 cells with increased Smad4 expression had decreased in vitro cell migration. The data suggested that restoration of Smad4 in Smad4-deficient cells may provide a potential therapeutic strategy for intervention of colon cancer migration and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284991     DOI: 10.1016/j.bbrc.2009.01.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Association of Wnt1/beta-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu-Feng Cao; Lv Ji; Bin Zhu; Lei Tao; Dong-dong Wang
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

Review 2.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

3.  Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).

Authors:  Beiyun Zhou; Yixin Liu; Michael Kahn; David K Ann; Arum Han; Hongjun Wang; Cu Nguyen; Per Flodby; Qian Zhong; Manda S Krishnaveni; Janice M Liebler; Parviz Minoo; Edward D Crandall; Zea Borok
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

4.  Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.

Authors:  Tanner J Freeman; J Joshua Smith; Xi Chen; M Kay Washington; Joseph T Roland; Anna L Means; Steven A Eschrich; Timothy J Yeatman; Natasha G Deane; R Daniel Beauchamp
Journal:  Gastroenterology       Date:  2011-11-22       Impact factor: 22.682

5.  Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu-Feng Cao; Lv Ji; Bin Zhu; Dong-dong Wang; Lei Tao; Su-Qing Li
Journal:  Med Oncol       Date:  2011-01-23       Impact factor: 3.064

6.  Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.

Authors:  Christina Stache; Annett Hölsken; Rudolf Fahlbusch; Jörg Flitsch; Sven-Martin Schlaffer; Michael Buchfelder; Rolf Buslei
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

7.  Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.

Authors:  Juthika Kundu; S M Riajul Wahab; Joydeb Kumar Kundu; Yoon-La Choi; Ozgur Cem Erkin; Hun Seok Lee; Sang Gyu Park; Young Kee Shin
Journal:  Int J Oncol       Date:  2012-06-12       Impact factor: 5.650

8.  Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells.

Authors:  K Birkenkamp-Demtroder; A Maghnouj; F Mansilla; K Thorsen; C L Andersen; B Øster; S Hahn; T F Ørntoft
Journal:  Br J Cancer       Date:  2011-07-19       Impact factor: 7.640

9.  Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

Authors:  Hiroshi Hirata; Koji Ueno; Varahram Shahryari; Yuichiro Tanaka; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  TGF-β - an excellent servant but a bad master.

Authors:  Lenka Kubiczkova; Lenka Sedlarikova; Roman Hajek; Sabina Sevcikova
Journal:  J Transl Med       Date:  2012-09-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.